Articles

Characterization of therapy-related acute myeloid leukemia: increasing incidence and prognostic implications

Department of Medicine, Huddinge, Division of Hematology, Karolinska Institutet, Stockholm
Department of Medical Sciences, Uppsala University, Uppsala
Department of Hematology, Sahlgrenska University Hospital, Gothenburg
Department of Hematology, Sahlgrenska University Hospital, Gothenburg
Department of Hematology, Skåne University Hospital, Lund, and Department of Hematology, Stem Cell Center, Department of Laboratory Medicine, Lund University, Lund
Department of Hematology, Linköping University Hospital, Linköping
Department of Hematology, Linköping University Hospital, Linköping
Department of Medicine, Huddinge, Division of Hematology, Karolinska Institutet, Stockholm
Department of Medical Sciences, Uppsala University, Uppsala
Department of Medicine, Huddinge, Division of Hematology, Karolinska Institutet, Stockholm
Department of Hematology, Norrland University Hospital, Umeå
Department of Hematology, Sahlgrenska University Hospital, Gothenburg
Department of Hematology, Sahlgrenska University Hospital, Gothenburg
Department of Hematology, Sundsvall Hospital, Sundsvall
Department of Medical Sciences, Uppsala University, Uppsala
Department of Hematology, Skåne University Hospital, Lund, and Department of Hematology, Stem Cell Center, Department of Laboratory Medicine, Lund University, Lund
Department of Medicine, Huddinge, Division of Hematology, Karolinska Institutet, Stockholm, Sweden; Department of Medical Sciences, Uppsala University, Uppsala
Haematologica Early view Aug 25, 2022 https://doi.org/10.3324/haematol.2022.281233